Can overall results of clinical trials be applied to all patients?
- PMID: 7783541
- DOI: 10.1016/s0140-6736(95)90120-5
Can overall results of clinical trials be applied to all patients?
Abstract
It is generally assumed that the overall results of a clinical trial are generalisable to all patients in the trial and all similar future patients; in other words, that the relative treatment effect in individual patients is similar to the overall trial result. Although this assumption underpins the application of trial results to clinical practice, it has rarely been tested. By independently derived prognostic models, the results of the European Carotid Surgery Trial and the UK-TIA Aspirin Trial were reanalysed to find out whether relative treatment effect varied with absolute baseline risk of stroke. There was significant heterogeneity of relative treatment effect in both trials, resulting in substantial variation in absolute treatment effect with predicted baseline risk. Although, on average, the application of overall trial results to all patients will do more good than harm, a knowledge of the association between relative treatment effect and absolute baseline risk will increase the cost-effectiveness of healthcare interventions by identifying those patients in whom treatment is ineffective and those patients who are most likely to benefit.
Comment in
-
Can overall results of clinical trials be applied to all patients?Lancet. 1995 Aug 12;346(8972):445-6. Lancet. 1995. PMID: 7623594 No abstract available.
-
Can overall results of clinical trials be applied to all patients?Lancet. 1995 Aug 12;346(8972):446. Lancet. 1995. PMID: 7677909 No abstract available.
Similar articles
-
Variation in the use of angiography and carotid endarterectomy by neurologists in the UK-TIA aspirin trial.Br Med J (Clin Res Ed). 1983 Feb 12;286(6364):514-7. doi: 10.1136/bmj.286.6364.514. Br Med J (Clin Res Ed). 1983. PMID: 6402129 Free PMC article. Clinical Trial.
-
Prediction of benefit from carotid endarterectomy in individual patients: a risk-modelling study. European Carotid Surgery Trialists' Collaborative Group.Lancet. 1999 Jun 19;353(9170):2105-10. doi: 10.1016/s0140-6736(98)11415-0. Lancet. 1999. PMID: 10382694 Clinical Trial.
-
Carotid endarterectomy. Management of transient ischemic attack and asymptomatic carotid stenosis.Surg Annu. 1995;27:185-98. Surg Annu. 1995. PMID: 7597550 Review. No abstract available.
-
Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST).Lancet. 1998 May 9;351(9113):1379-87. Lancet. 1998. PMID: 9593407 Clinical Trial.
-
Endarterectomy for symptomatic carotid stenosis. Review of the European and North American Symptomatic Carotid Surgery Trials.Nebr Med J. 1992 Jun;77(6):121-3. Nebr Med J. 1992. PMID: 1620265 Review.
Cited by
-
Method for evaluating prediction models that apply the results of randomized trials to individual patients.Trials. 2007 Jun 5;8:14. doi: 10.1186/1745-6215-8-14. Trials. 2007. PMID: 17550609 Free PMC article.
-
Symptomatic and asymptomatic carotid stenosis: how, when, and who to treat?Curr Atheroscler Rep. 2006 Jul;8(4):290-7. doi: 10.1007/s11883-006-0006-z. Curr Atheroscler Rep. 2006. PMID: 16822394 Review.
-
How the type of risk reduction influences required sample sizes in randomised clinical trials.Ann Rheum Dis. 2004 Nov;63(11):1368-71. doi: 10.1136/ard.2003.014035. Epub 2004 Jul 1. Ann Rheum Dis. 2004. PMID: 15231507 Free PMC article.
-
Applying machine learning to predict real-world individual treatment effects: insights from a virtual patient cohort.J Am Med Inform Assoc. 2019 Oct 1;26(10):977-988. doi: 10.1093/jamia/ocz036. J Am Med Inform Assoc. 2019. PMID: 31220274 Free PMC article.
-
The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement.Ann Intern Med. 2020 Jan 7;172(1):35-45. doi: 10.7326/M18-3667. Epub 2019 Nov 12. Ann Intern Med. 2020. PMID: 31711134 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
